Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Neurofeedback treatment for women with bulimia nervosa

Official title: Neurofeedback During Eating: A Novel Mechanistic Treatment for Bulimia Nervosa

Run by Icahn School of Medicine at Mount Sinai · NCT05614024 · Data updated 2026-11-12

This study tests if a new brain training method can help women with bulimia nervosa improve their control over eating and reduce their symptoms.

More Bulimia Nervosa trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment30 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 13, 2024
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedNovember 4, 2026
Trial IDNCT05614024 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 45 who meet the diagnostic criteria for bulimia nervosa and have a body mass index between 18.5 and 30 kg/m2.

Probably not a fit

Patients currently undergoing psychotherapy focused on eating disorder symptoms or those with significant medical or psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of noninvasive neurofeedback targeting the prefrontal cortex during eating in women diagnosed with bulimia nervosa. Participants will be randomly assigned to receive either real or sham neurofeedback while eating, using a wearable brain imaging device called functional near-infrared spectroscopy (fNIRS). The study aims to assess how this neurofeedback training may enhance inhibitory control and alleviate symptoms associated with bulimia nervosa. Data collection includes assessments before and after the neurofeedback session, along with follow-up evaluations.

Why it matters

Potential benefit: If successful, this approach could improve inhibitory control and reduce symptoms of bulimia nervosa in affected individuals.

How similar studies have gone: While the use of neurofeedback in eating disorders is an emerging field, similar studies have shown promise in other conditions, suggesting potential for success in this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Female
* Aged 18 to 45 years
* Meet diagnostic criteria for bulimia nervosa
* Current body mass index greater than or equal to 18.5kg/m2 but under 30kg/m2
* English-speaking

Exclusion criteria:

* Ongoing medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation
* Current psychotherapy focused primarily on eating disorder symptoms
* Pregnancy or planned pregnancy, or lactation during the study period
* Allergy to ingredients in the standardized meal or in the shake

Where it's running

  • Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Laura A Berner, Ph.D. — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Sila Sozeri, B.A.
  • Email: sila.sozeri@mssm.edu
  • Phone: (212) 201-2679

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Eating Disorder Dynamic Intervention

    A digital program is tested to help adults with eating disorders by sending real-time, personalized coping tips based on smartphone surveys and sensor data.

    Recruiting Trustees of Dartmouth College · Lebanon, New Hampshire · NCT07600671

  • Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa

    In women with bulimia nervosa, this study tests whether real-time brain feedback during eating, paired with a 4-week text-message program, can help improve self-control and reduce symptoms.

    Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07581158

  • MDMA-assisted therapy for bulimia nervosa

    This study tests whether MDMA-assisted therapy can help people with bulimia nervosa over a 10-week period.

    Recruiting Phase 1 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07542145

  • Cognitive evaluation for people with eating disorders

    This project tests whether thinking skills (like cognitive flexibility and inhibitory control) and automatic food-related attitudes differ among people aged 14–65 with ARFID, anorexia, or bulimia.

    Recruiting at 3 sites Istituti Clinici Scientifici Maugeri SpA · Pavia, PV and 2 other locations · NCT07478510

  • An AI chatbot to help teens and young adults with eating disorders manage anxiety about weight gain

    This project will test an AI-powered chatbot that delivers exposure-based exercises to help adolescents and young adults in a partial hospitalization program reduce anxiety about weight gain.

    Recruiting Milton S. Hershey Medical Center · Hershey, Pennsylvania · NCT07237607

  • Digital twins to classify mental health patterns in adults with diabetes

    This project will try to create 'digital twin' profiles that combine glucose, mood, and behavior data to track mental health patterns in adults with diabetes.

    Recruiting Forschungsinstitut der Diabetes Akademie Mergentheim · Bad Mergentheim, Baden-Wurttemberg and 2 other locations · NCT07212075

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.